Hidradenitis suppurativa
Clinical research in hidradenitis suppurativa focuses on moderate-to-severe disease, with attention to both symptom control and longer-term safety and tolerability outcomes.
- Inflammatory skin disease
- Moderate-to-severe hidradenitis suppurativa
- Long-term safety
Trials in this area reflect interest in persistent cutaneous inflammation and treatment response over extended follow-up.
Psoriatic arthritis
Research in psoriatic arthritis centers on active disease, with outcomes linked to improvement in joint inflammation, clinical response, and ongoing treatment tolerability.
- Active psoriatic arthritis
- Joint inflammation
- Long-term efficacy
This therapeutic area also includes patients with prior treatment exposure and those with biologic-naive disease.
Palmoplantar pustulosis
Studies in palmoplantar pustulosis address localized pustular psoriasis affecting the palms and soles, with emphasis on improvement in disease severity and visible inflammatory burden.
- Palmoplantar pustulosis
- Pustular psoriasis
- Skin severity assessment
Work in this field highlights interest in difficult-to-treat dermatologic inflammation.
Axial spondyloarthritis
Clinical activity in axial spondyloarthritis reflects interest in inflammatory disease of the spine and sacroiliac joints, including imaging-based assessment of active lesions and disease activity.
- Axial spondyloarthritis
- Inflammatory back disease
- Imaging biomarkers
These studies connect musculoskeletal inflammation with molecular imaging approaches.
Immunology and inflammatory disease
The sponsor’s trial portfolio is concentrated in immune-mediated inflammatory disorders, spanning dermatology and rheumatology with shared mechanisms of chronic inflammation.
- Immune-mediated disease
- Dermatology
- Rheumatology
Across these areas, the clinical focus includes inflammatory pathways, symptom burden, and sustained treatment effects.
